TUMOR MARKERS IN EPITHELIAL OVARIAN CANCER
- 1 March 1994
- journal article
- Published by Elsevier in Obstetrics and Gynecology Clinics of North America
- Vol. 21 (1) , 41-61
- https://doi.org/10.1016/s0889-8545(21)00306-5
Abstract
No abstract availableThis publication has 73 references indexed in Scilit:
- Coordinate elevation of serum markers in ovarian cancer but not in benign diseaseCancer, 1991
- Serum CA 125 in epithelial ovarian cancer. A longitudinal studyBJOG: An International Journal of Obstetrics and Gynaecology, 1987
- CA 125 Serum Levels Correlated With Second-Look Operations Among Ovarian Cancer PatientsObstetrics & Gynecology, 1986
- CA 125 surveillance and second-look laparotomy in ovarian carcinomaAmerican Journal of Obstetrics and Gynecology, 1986
- CA19-9 as a marker for ovarian cancer: Alone and in comparison with CA125British Journal of Cancer, 1985
- Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour markerBritish Journal of Cancer, 1984
- Monitoring human ovarian carcinoma with a combination of CA 125, CA 19-9, and carcinoembryonic antigenAmerican Journal of Obstetrics and Gynecology, 1984
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983
- Carcinoembryonic Antigen (CEA) and Carbohydrate Determinant 19–9 (CA 19–9) Localization in 121 Primary and Metastatic Ovarian TumorsInternational Journal of Gynecological Pathology, 1982
- Reactivity of a monoclonal antibody with human ovarian carcinoma.Journal of Clinical Investigation, 1981